Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acetylator phenotype in psoriasis.

L C Jiménez-Nieto1, J M Ladero, M J Fernández-Gundín

  • 1Department of Medicine, Hospital Universitario San Carlos, Universidad Complutense, Madrid, Spain.

Dermatologica
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Logistic map trajectory distributions: Renormalization-group, entropy, and criticality at the transition to chaos.

Chaos (Woodbury, N.Y.)·2021
Same author

Retronychia: an underdiagnosed disease.

Dermatology online journal·2018
Same author

Quasiperiodic graphs at the onset of chaos.

Physical review. E, Statistical, nonlinear, and soft matter physics·2014
Same author

Möbius transformations and electronic transport properties of large disorderless networks.

Physical review. E, Statistical, nonlinear, and soft matter physics·2012
Same author

A case of continuous pustular acrodermatitis of hallopeau.

Actas dermo-sifiliograficas·2010
Same author

Treatment of cutaneous tuberculosis with calcium and vitamin D, in massive doses (Charpy treatment).

Actas dermo-sifiliograficas·2010

Slow acetylator phenotype, a metabolic trait, may be a genetic risk factor for developing psoriasis. This finding suggests a potential link between how the body processes drugs and the development of this skin condition.

Area of Science:

  • Pharmacogenetics
  • Dermatology
  • Human Genetics

Background:

  • The acetylator phenotype influences drug metabolism.
  • Psoriasis is a complex inflammatory skin disease with potential genetic underpinnings.
  • Previous research has explored genetic factors in psoriasis etiology.

Purpose of the Study:

  • To investigate the association between acetylator phenotype and psoriasis.
  • To determine if slow acetylator phenotype is more prevalent in psoriatic patients compared to controls.
  • To explore the role of slow acetylator phenotype as a potential genetic risk factor for psoriasis.

Main Methods:

  • Acetylator phenotype was determined using sulfamethazine.
  • The study included 64 patients with psoriasis and 157 normal control subjects.

Related Experiment Videos

  • Statistical analysis was performed to compare phenotype frequencies between groups.

    • Main Results:

    • No significant difference in slow acetylator prevalence was found between psoriatic patients (62.5%) and controls (57.3%).
    • However, a significantly higher proportion of patients with psoriatic siblings (81%) were slow acetylators (p < 0.05).
    • This suggests a potential genetic link within families affected by psoriasis.

    Conclusions:

    • Slow acetylator phenotype may represent a genetic risk factor contributing to the development of psoriasis.
    • The association appears stronger in patients with a family history of the disease.
    • Further research is warranted to elucidate the precise role of pharmacogenetics in psoriasis pathogenesis.